Avoid common mistakes on your manuscript.
1 Correction to: PharmacoEconomics – Open (2022) 6:315–328 https://doi.org/10.1007/s41669-021-00311-5
This article incorrectly reported that the two German health technology assessment (HTA) bodies, G-BA and IQWiG, only assess pharmaceuticals. The article should have indicated that these bodies also evaluate medical devices and other health technologies. The article and supplement have been corrected.
In addition, the name of the Austrian HTA body has been updated from “Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA)” to “Austrian Institute for Health Technology Assessment (AIHTA)”, as AIHTA was established in March 2020 to succeed LBI-HTA. Finally, the term “HTA authority” has been changed to “HTA body” throughout the manuscript to avoid any confusion to the reader, as the term “authority” might be misinterpreted as meaning that the HTA recommendations are legally binding.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Fontrier, AM., Visintin, E. & Kanavos, P. Correction to: Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries. PharmacoEconomics Open 6, 629 (2022). https://doi.org/10.1007/s41669-022-00345-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41669-022-00345-3